These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
423 related items for PubMed ID: 11174335
1. Bleeding risks with abciximab after full-dose thrombolysis in rescue or urgent angioplasty for acute myocardial infarction. Jong P, Cohen EA, Batchelor W, Lazzam C, Kreatsoulas C, Natarajan MK, Strauss BH. Am Heart J; 2001 Feb; 141(2):218-25. PubMed ID: 11174335 [Abstract] [Full Text] [Related]
2. Bleeding events with abciximab in acute coronary syndromes without early revascularization: An analysis of GUSTO IV-ACS. Lenderink T, Boersma E, Ruzyllo W, Widimsky P, Ohman EM, Armstrong PW, Wallentin L, Simoons ML, GUSTO IV-ACS Investigators. Am Heart J; 2004 May; 147(5):865-73. PubMed ID: 15131544 [Abstract] [Full Text] [Related]
3. Hemorrhagic and vascular complications after percutaneous coronary intervention with adjunctive abciximab. Cote AV, Berger PB, Holmes DR, Scott CG, Bell MR. Mayo Clin Proc; 2001 Sep; 76(9):890-6. PubMed ID: 11560299 [Abstract] [Full Text] [Related]
11. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. Montalescot G, Barragan P, Wittenberg O, Ecollan P, Elhadad S, Villain P, Boulenc JM, Morice MC, Maillard L, Pansiéri M, Choussat R, Pinton P, ADMIRAL Investigators. Abciximab before Direct Angioplasty and Stenting in Myocardial Infarction Regarding Acute and Long-Term Follow-up. N Engl J Med; 2001 Jun 21; 344(25):1895-903. PubMed ID: 11419426 [Abstract] [Full Text] [Related]
12. A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel. Kastrati A, Mehilli J, Schühlen H, Dirschinger J, Dotzer F, ten Berg JM, Neumann FJ, Bollwein H, Volmer C, Gawaz M, Berger PB, Schömig A, Intracoronary Stenting and Antithrombotic Regimen-Rapid Early Action for Coronary Treatment Study Investigators. N Engl J Med; 2004 Jan 15; 350(3):232-8. PubMed ID: 14724302 [Abstract] [Full Text] [Related]
13. Outcome in elderly patients undergoing primary coronary intervention for acute myocardial infarction: results from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. Guagliumi G, Stone GW, Cox DA, Stuckey T, Tcheng JE, Turco M, Musumeci G, Griffin JJ, Lansky AJ, Mehran R, Grines CL, Garcia E. Circulation; 2004 Sep 21; 110(12):1598-604. PubMed ID: 15353506 [Abstract] [Full Text] [Related]
14. Combined Abciximab REteplase Stent Study in acute myocardial infarction (CARESS in AMI). Di Mario C, Bolognese L, Maillard L, Dudek D, Gambarati G, Manari A, Guiducci V, Patrizi G, Rusconi LC, Piovaccari G, Hibon AR, Belpomme V, Indolfi C, Olivari Z, Steffenino G, Zmudka K, Airoldi F, Panzarasa R, Flather M, Steg PG. Am Heart J; 2004 Sep 21; 148(3):378-85. PubMed ID: 15389222 [Abstract] [Full Text] [Related]